2-Oxoquinoline-based-thiosemicarbazones as multitargeting neurotherapeutics against Alzheimer's disease: In vitro and in silico studies of MAO and ChE inhibitors.
Arch Pharm (Weinheim)
; 356(11): e2300430, 2023 Nov.
Article
en En
| MEDLINE
| ID: mdl-37718357
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Tiosemicarbazonas
/
Quinolonas
/
Enfermedad de Alzheimer
Idioma:
En
Revista:
Arch Pharm (Weinheim)
Año:
2023
Tipo del documento:
Article